Commonwealth Equity Services LLC boosted its holdings in Aurora Cannabis Inc (NYSE:ACB) by 77.5% in the 1st quarter, Holdings Channel reports. The firm owned 583,961 shares of the company’s stock after buying an additional 254,948 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Aurora Cannabis were worth $5,290,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in ACB. Moisand Fitzgerald Tamayo LLC acquired a new position in Aurora Cannabis in the first quarter valued at $25,000. Carroll Financial Associates Inc. acquired a new position in Aurora Cannabis in the first quarter valued at $27,000. Financial Management Professionals Inc. increased its stake in Aurora Cannabis by 586.3% during the first quarter. Financial Management Professionals Inc. now owns 3,061 shares of the company’s stock worth $28,000 after acquiring an additional 2,615 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Aurora Cannabis during the fourth quarter worth about $29,000. Finally, Burt Wealth Advisors increased its stake in Aurora Cannabis by 1,033.3% during the first quarter. Burt Wealth Advisors now owns 3,400 shares of the company’s stock worth $31,000 after acquiring an additional 3,100 shares during the last quarter. Hedge funds and other institutional investors own 9.02% of the company’s stock.
Several equities research analysts have commented on ACB shares. Seaport Global Securities started coverage on Aurora Cannabis in a research note on Thursday, February 21st. They set a “neutral” rating for the company. Jefferies Financial Group started coverage on Aurora Cannabis in a research note on Monday, February 25th. They set a “buy” rating for the company. TheStreet lowered Aurora Cannabis from a “c” rating to a “d+” rating in a research note on Monday, February 25th. Cowen started coverage on Aurora Cannabis in a research note on Tuesday, March 5th. They set an “outperform” rating for the company. Finally, GMP Securities upgraded Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Wednesday, March 13th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Aurora Cannabis presently has a consensus rating of “Buy” and a consensus price target of $9.86.
Shares of NYSE:ACB opened at $7.57 on Friday. The stock has a market cap of $7.86 billion, a price-to-earnings ratio of 63.08 and a beta of 2.80. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. Aurora Cannabis Inc has a 12 month low of $4.05 and a 12 month high of $12.52.
TRADEMARK VIOLATION WARNING: This report was posted by Riverton Roll and is the sole property of of Riverton Roll. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://rivertonroll.com/news/2019/06/14/commonwealth-equity-services-llc-has-5-29-million-position-in-aurora-cannabis-inc-nyseacb.html.
Aurora Cannabis Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc (NYSE:ACB).
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.